Pricing Log in Create free account

NeuroPace, Inc. (NPCE) vs Sight Sciences, Inc. (SGHT)

NeuroPace, Inc. and Sight Sciences, Inc. are both Medical Devices companies. Sight Sciences, Inc. is the larger, with a market value of $484.8M against $438.7M — 1.1× the size. NeuroPace, Inc. grew revenue faster over the last twelve months: 21.7% against 9.27%. NeuroPace, Inc. has the higher net margin (−18.6% vs −35.7%) and the higher return on invested capital (−44.6% vs −125.2%). Across the 18 metrics below, NeuroPace, Inc. leads on 12 and Sight Sciences, Inc. on 6.

Valuation

Metric NPCE SGHT Medical Devices median
P/E n/m n/m 23.22
P/S 4.06 5.41 2.34
P/B 35.13 8.53 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 4.16 4.95 2.24
Earnings yield (4.66%) (6.76%) (10.09%)
Free cash flow yield (2.78%) (5.17%) (8.47%)

Profitability

Metric NPCE SGHT Medical Devices median
Gross margin 78.38% 87.96% 56.01%
Operating margin (13.33%) (33.43%) (15.03%)
Net margin (18.58%) (35.69%) (20.40%)
Free cash flow margin (11.29%) (27.98%) (7.24%)
Return on equity (122.05%) (48.42%) (15.32%)
Return on assets (18.82%) (26.24%) (19.72%)
Return on invested capital (44.64%) (125.18%) (10.33%)

Growth

Metric NPCE SGHT Medical Devices median
Revenue growth (TTM) 21.65% 9.27% 8.80%
EPS growth (last fiscal year) 29.03% 28.16% 29.03%
Revenue growth, 5-year CAGR 19.44% 22.86% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NPCE SGHT Medical Devices median
Debt to equity 4.97 0.77 0.07
Current ratio 4.94 4.95 2.50
Net debt to EBITDA 0.15 1.45 0.49

Dividend

Metric NPCE SGHT Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric NPCE SGHT Medical Devices median
Market cap 438.66m 484.78m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack